In recent days, the digital healthcare sector has seen a significant surge in the integration of artificial intelligence (AI) technologies, with leading companies like Yidu Healthcare, EagleEye Technology, Wanda Information, and Zhiyun Health publicly announcing their adoption of the DeepSeek modelThis movement signifies an effort to not only enhance healthcare processes but also to expedite the practical application of AI within medical settingsIndustry experts posit that the implications of AI in healthcare — ranging from improving medical device functionality to aiding in the interpretation of diagnostics and supporting clinical decision-making — cannot be overstatedAs the landscape of healthcare evolves, it is imperative for hospitals and medical enterprises to prioritize these innovations, which could enhance their competitive edge and position in the industry.
Enhancing data extraction capabilities is one of the primary focuses for these companiesRecent announcements reveal that several digital medical enterprises have integrated DeepSeek into their systemsFor instance, on February 7, EagleEye Technology upgraded its self-developed WanYu medical model and linked it to the DeepSeek-R1 modelThis upgrade leverages a decade of expertise in the healthcare vertical, encompassing over 30 million clinical diagnosis data points, 800 evidence-based medicine knowledge graphs, and an in-depth analysis of diagnostic pathways from top-tier hospitalsThis integration allows for a marked improvement in clinical diagnostic efficiency and accuracy, enhanced report interpretations, and more personalized health management experiences.
Just a day prior, on February 6, Yidu Healthcare disclosed that it has fused the DeepSeek AI model into its proprietary "AI Medical Brain," known as YiduCoreThis move aims to catalyze a more extensive and innovative application of AI technology across the healthcare industryThe integration of DeepSeek augments YiduCore's capabilities in extracting valuable data insights, resulting in the production of highly accurate disease analysis reports
Advertisements
This fortifies the connection between data and practical healthcare scenarios, providing robust intelligent support for research, treatment, and public health initiatives, while also reducing costs and improving efficiency in the healthcare supply chainAs of September 30, 2024, YiduCore is reported to have processed and analyzed over 5.5 billion authorized medical records across a network of more than 2,800 hospitals, with its disease knowledge graph now covering virtually all known ailments.
On the same day, Zhiyun Health announced its integration of the DeepSeek-R1 model into its self-developed medical AI system, "Zhiyun Brain." This step is set to amplify the data extraction abilities of Zhiyun's AI mechanisms, thereby increasing the efficiency of digital chronic disease management and ultimately enhancing the production capabilities of healthcare AI.
The introduction of models like DeepSeek is recognized by industry insiders as a catalyst for technology advancement, performance enhancement, and cost reductionThe potential to address longstanding challenges in the AI healthcare sector — such as small sample learning, high costs, and inaccuracies — could lead to transformative changes within the industry.
Looking ahead, the prospects for AI in the healthcare market appear exceedingly brightAccording to data from Frost & Sullivan, the scale of China's AI healthcare market is poised to rise dramatically, from 8.8 billion yuan in 2023 to an estimated 315.7 billion yuan by 2033, reflecting a compound annual growth rate (CAGR) of 43.1% over the decade.
In recent years, China has unveiled a series of policies aimed at fostering sustainable growth within the AI healthcare landscapeNotably, a document released in November 2024 by the National Health Commission and other governmental bodies delineates the application scenarios of AI within healthcare, focusing on four main domains: the intersection of AI with medical service management, grassroots public health services, health industry development, and medical education and research
Advertisements
The guide further details 84 specific fields of application, including intelligent diagnostic assistance in medical imaging.
Moreover, there is ongoing exploration into the application of technologies such as artificial intelligence, cloud computing, and big data within research and development realmsThere is a growing emphasis on analyzing biological data to enhance the efficiency of new target and drug discovery, along with the construction of experimental animal models that support drug design, pharmacological and efficacy studies, clinical trials, and data analysis — all while reducing development costs.
In a progressive move towards health insurance reforms, authorities have for the first time included modern technologies such as AI-assisted diagnostics and cloud storage in the pricing structure, thereby integrating these innovations into main project categories related to radiologic examinations.
Locally, various regions are actively aligning with national strategies, implementing policies to stimulate the deep integration of AI with medical innovationA prime example is Shanghai's ambition to become a global hub for medical AI technology innovation and application demonstrations.
Analysts at Haitong International view AI as a paramount trend within the healthcare arenaThey assert that the recent slew of policies is formalizing and accelerating the development of AI in medical fields, hinting that advancements in AI technology alongside progressively realized application scenarios will uncover significant growth potential for the AI healthcare industry.
Investors are advised to consider opportunities arising from the robust interconnections along the healthcare industry chainAccording to research from Yongxing Securities, the application of AI in healthcare stands to revamp traditional medical paradigms and unveil new growth prospects, prompting a closer inspection of pharmaceutical firms strategically positioning within the AI healthcare landscape.
In light of the promising market outlook, publicly traded pharmaceutical companies are aggressively integrating AI into their operations
Advertisements
Advertisements
Advertisements